New tool aims to curb overtreatment of Low-Risk thyroid cancer
NCT ID NCT06073223
First seen Nov 19, 2025 · Last updated May 22, 2026 · Updated 19 times
Summary
This study tested a new tool called CQUPLE to see if it helps patients with low-risk thyroid cancer make better-informed treatment decisions. Fifty adults aged 18 to 80 with newly diagnosed low-risk thyroid cancer took part. Half received the CQUPLE tool before their surgeon visit, while the other half got usual care. The researchers measured how acceptable and feasible the tool was, and whether it changed the treatment people chose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The University of Michigan Cancer Center
Ann Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.